ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Alloantibodies"

  • 2017 American Transplant Congress

    TACI Polymorphisms Associated with De Novo Alloantibodies in Humans and Allograft Rejection in Mice.

    J. Platt,1 E. Farkash,2 A. Lefferts,1 M. Samaniego,3 M. Cascalho.1

    1Surgery, University of Michigan, Ann Arbor, MI; 2Pathology, University of Michigan, Ann Arbor, MI; 3Internal Medicine, University of Michigan, Ann Arbor, MI

    A. Trans-membrane Activator and CAML Interactor (TACI) controls B cell differentiation and memory and exists as numerous allelic variants among healthy individuals and individuals with…
  • 2017 American Transplant Congress

    Rapid Depletion of Circulating DSA and Treatment of Acute Antibody-Mediated Rejection with the Combination of CTLA-4Ig/Belatacept and Bortezomib in Mouse and Man.

    J. Young,1 A. Vannier,1 G. Bumgardner,2 A. Chong,1 R. Pelletier.2

    1Sugery, University of Chicago, Chicago, IL; 2Surgery, The Ohio State University, Columbus, OH

    Antibody mediated rejection (AMR) is a major cause of rejection, and there are limited therapeutic options for reversing alloantibody production when it is fully established.…
  • 2017 American Transplant Congress

    Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

    V. Kosmoliaptsis,1 C. Kling,2 M. Robb,3 D. Collett,3 J. Bradley,1 C. Taylor,1 D. Kabelitz,2 D. Mallon.1

    1Department of Surgery, University of Cambridge, Cambridge, United Kingdom; 2University of Kiel, Kiel, Germany; 3NHS Blood and Transplant, Bristol, United Kingdom

    Background: Our preliminary work indicates that donor HLA immunogenicity in kidney and haematopoietic stem cell transplantation can be predicted by comparative assessment of donor and…
  • 2017 American Transplant Congress

    Effects of Tofacitinib (JAK-3 Inhibitor) on De Novo HLA-A2 Antibody Production in a Mouse Model of Allo-Sensitization.

    N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    Purpose: Tofacitinib is a Janus Kinase Inhibitor currently approved by FDA for treatment of rheumatoid arthritis. In considering its effect in reducing B cell proliferation…
  • 2017 American Transplant Congress

    De Novo Donor-Specific Antibodies After Allograft Nephrectomy.

    G. Lucisano,1 P. Brookes,2 E. Santos-Nunez,2 N. Firmin,2 N. Gunby,2 S. Hassan,1 A. Gueret-Wardle,1 M. Willicombe,1 D. Taube.1

    1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom

    Introduction: although the development of donor-specific antibodies (DSAs) is a known event after allograft nephrectomy (Nx), there are few studies describing the tempo, class and…
  • 2017 American Transplant Congress

    Endocapillary NK Cells Are Increased in Indication Renal Transplant Biopsies with Antibody and T Cell Mediated Rejection.

    A. Shammout, J. Barnes, E. Farkash.

    Pathology, University of Michigan Medical School, Ann Arbor, MI

    Detection of NK cell transcripts in renal transplant biopsies is associated with antibody mediated rejection (AMR). Similarly, quantification of endocapillary NK cells in paraffin tissue…
  • 2017 American Transplant Congress

    Predictive Value of Pre-Transplant Cross-Match Techniques on Living Donor Kidney Transplant Outcomes.

    M. Meneghini,1 E. Melilli,1 I. Revuelta,3 R. Rajalingam,2 E. Rigol,4 S. Chandran,2 F. Diekmann,3 F. Vincenti,2 J. Cruzado,1 J. Martorell,4 O. Bestard.1

    1Kidney Transplant Unit, Bellvitge University Hospital; IDIBELL, Barcelona, Spain; 2Kidney Transplant Unit, UCSF Medical Centre, SanFrancisco; 3Kidney Transplant Unit, Clinic University Hospital, Barcelona, Spain; 4Immunology Department, Clinic University Hospital, Barcelona, Spain

    Study aim: To investigate the impact of different cross-match techniques and their combination before living-donor kidney transplantation(LDKT) on main clinical outcomes.Methods: Retrospective study including 394…
  • 2017 American Transplant Congress

    Differential Effect of Antibody Removal on ABO Blood Group Type Chain Specific Antibodies Over Time.

    A. Bentall,1 M. Jeyakanthan,2 J. Pearcey,2 B. Motyka,2 C. Cairo,3 T. Lowary,3 J. Buriak,4 L. West,2 S. Ball.1

    1Department of Nephrology, University Hospital Birmingham, Birmingham, United Kingdom; 2Departs of Pediatrics, Surgery and Immunology, University of Alberta, Alberta Transplant Institute, Edmonton, Canada; 3Alberta Glycomics Centre, Univ of Alberta, Dept of Chemistry, Edmonton, Canada; 4Dept of Chemistry, National Institute of Nanotechnology, Edmonton, Canada

    Introduction: The trisaccharide epitope defines A&B blood group antigens where antibody binds to subtype chains (I-VI), but only subtype II is expressed on cardiac vascular…
  • 2017 American Transplant Congress

    Significant Allosensitisation Despite Early, within 24 Hour, Graft Nephrectomy.

    G. Lucisano,1 P. Brookes,2 E. Santos-Nunez,2 N. Firmin,2 N. Gunby,2 S. Hassan,1 A. Gueret-Wardle,1 M. Willicombe,1 D. Taube.1

    1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom

    Introduction: Although it is well known that allograft nephrectomy (Nx) is followed by the development of donor-specific antibodies (DSAs) even after a short transplant period,…
  • 2017 American Transplant Congress

    Strategy for Analysis of Donor-Specific Antibody Repertoire: Paired Immunoglobulin Heavy and Light Chain Analysis of Individual Memory B Cells.

    M. Lucia,1 A. Gomez,2 S. Luque,3 O. Bestard,3 W. Robinson,2 O. Martinez.1

    1Surgery, Stanford School of Medicine, Stanford; 2Medicine, Stanford School of Medicine, Stanford; 3Nephrology, IDIBELL, Barcelona, Catalonia, Spain

    Antibody-mediated rejection (ABMR) is the most challenging immunological barrier to overcome in human transplantation and one of the most prevalent causes of kidney allograft loss.…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 40
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences